SC

Sayyed Cherkkarapaduvingle Imbichi

Director Director DIN 02630437
DIN 02630437 First appointment May 2009 Primary industry Machinery and Equipment
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since May 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Sayyed Cherkkarapaduvingle Imbichi

Data last updated:

Sayyed Cherkkarapaduvingle Imbichi was a Director at Cavendish Bio Pharma Private Limited (2009–2012). The company operates in Machinery and Equipment.

DIN 02630437
Primary Designation Director
Industry Machinery and Equipment
First Appointment 02 May 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cavendish Bio Pharma Private Limited U24234TN2005PTC057399
Director02 May 20092005₹39.5 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cavendish Bio Pharma Private Limited
Premium access

Shareholding and investment profile for Sayyed Cherkkarapaduvingle Imbichi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sayyed Cherkkarapaduvingle Imbichi

Sayyed Cherkkarapaduvingle Imbichi was first appointed on 02 May 2009 as Director at Cavendish Bio Pharma Private Limited.

Sayyed Cherkkarapaduvingle Imbichi held 1 earlier board appointment: Cavendish Bio Pharma Private Limited (Director, 02 May 2009 to 13 Sep 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available